What do we do?

We are experts in performing and coordinating innovative research of all phases at Imperial College London and Imperial College Healthcare NHS Trust. We proactively promote multidisciplinary research and eagerly collaborate within the college as well as externally with research centres and institutes.

studies at ICORG

Contact

Western Eye Hospital
3rd Floor, A&E side
153 - 173 Marylebone Road
London NW1 5QH
+44 (0)20 3312 3206
imperial.icorg@nhs.net
Twitter: @ImperialOph

Serge Miodragovic, ICORG Manager
serge.miodragovic1@nhs.net

News & Events

Related Themes

Aim

Our aim is to optimise the establishment of new diagnostic methods of early disease and identify early markers of cell processes in neurodegenerative disease.  We seek opportunities to investigate new therapeutic treatments for ocular diseases, including discovering and developing novel modes of drug delivery and improved treatment strategies.

Studies

 

 

 

 

 

Why is this important?

Currently in the UK there is estimated to be around 1.58 to 2.31 million people affected with sight-loss and blindness as a result of ocular diseases such as age-related macular degenerative disease (AMD), cataract, diabetic retinopathy and glaucoma. By researching methods of diagnosis and therapeutic treatments we are able to improve patient-care in the community; positively impacting future generations diagnosed with ocular diseases to prevent blindness and avoid disability.

Research areas

  • Glaucoma - primary open angle glaucoma (POAG), acute angle glaucoma, ocular hypertension
  • Macular - age-related macular degeneration (AMD), diabetic macular oedema (DMO), polypoidal choroidal vasculopathy, macular telangiectasia (MacTel)
  • Oculoplastics, vitreoretinal, cataracts, genetic, paediatric

Summary of some of our current research

Summary of some of our current research

Investigator-led
  • DARC, PHASE 2 - The DARC Technology (Detection of Ppoptosing Retinal Cells) is a novel technique that utilises the unique optical properties of the eye to allow direct visualisation of retinal nerve cells dying through the process of apoptosis.
  • POPPY - Perforated punctal plug as an alternative to the three snip punctoplasty for the treatment of acquired lacrimal punctum.
  • LT-ROP - Long-term outcomes in adults with a history of retinopathy of prematurity (ROP)
  • WIGS study – the effects of water drinking in patients with open-angle glaucoma
  • SUSY – Comparing tissue reactions and scarring with two different types of suture.
  • Concept – Comparing the effectiveness of PhacoemulsificatioN + ECP laser and Phacoemulsification alone.

Tabs

Get involved
Patient and Public Involvement
Support
 

Our team

Prof M Francesca Cordeiro

Prof M Francesca Cordeiro
Professor of Ophthalmology, Director of ICORG

Eduardo Maria Normando

Eduardo Maria Normando
Clinical Senior Lecturer

Prof Philip Bloom

Prof Philip Bloom
Professor of Ophthalmology

Zena Rodrigues

Zena Rodrigues
Ophthalmic Nurse Consultant

Fabiana D'Esposito

Fabiana D'Esposito
Consultant Ophthalmologist, Genetics

Faisal Ahmed

Faisal Ahmed
Consultant Ophthalmic Surgeon

Rahila Zakir

Rahila Zakir
Consultant Ophthalmic & Vitreoretinal Surgeon

Saad Younis

Saad Younis
Consultant Ophthalmic Surgeon, Medical Retina Lead

Ali Mearza

Ali Mearza
Consultant Ophthalmic Surgeon, Western Eye Hospital Clinical Director

Tessa Fayers

Tessa Fayers
Consultant Ophthalmologist

Timothy Edward Yap

Timothy Edward Yap
Clinical Research Fellow

Research Areas